| Date | Panel | Item | Activity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| COVID-19 research v0.66 | IL17A | Ivone Leong Classified gene: IL17A as Green List (high evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| COVID-19 research v0.66 | IL17A | Ivone Leong Added comment: Comment on list classification: Promoted from Amber to Green as there is enough evidence in the literature to support this. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| COVID-19 research v0.66 | IL17A | Ivone Leong Gene: il17a has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| COVID-19 research v0.59 | IL17A |
Abdelazeem Elhabyan commented on gene: IL17A: I agree that the level should be reviewed for being increased to Green especially the association of SNPs with H1N1 (influenza A) and influenza B. Association with CNVs with pathology has been confirmed but the disease state was not revealed in any of the patients https://www.ncbi.nlm.nih.gov/clinvar?LinkName=gene_clinvar&from_uid=3605 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| COVID-19 research v0.59 | IL17A | Abdelazeem Elhabyan edited their review of gene: IL17A: Changed rating: GREEN | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| COVID-19 research v0.59 | IL17A | Abdelazeem Elhabyan Deleted their comment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| COVID-19 research v0.59 | IL17A |
Abdelazeem Elhabyan changed review comment from: I agree that the level should be reviewed for being increased to Green especially the association of SNPs with H1N1 (influenza A) and influenza B. Association with CNVs with pathology has been confirmed but the disease state was not revealed in any of the patients https://www.ncbi.nlm.nih.gov/clinvar?LinkName=gene_clinvar&from_uid=3605; to: I agree that the level should be reviewed for being increased to Green especially the association of SNPs with H1N1 (influenza A) and influenza B. Association with CNVs with pathology has been confirmed but the disease state was not revealed in any of the patients https://www.ncbi.nlm.nih.gov/clinvar?LinkName=gene_clinvar&from_uid=3605 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| COVID-19 research v0.59 | IL17A | Abdelazeem Elhabyan commented on gene: IL17A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| COVID-19 research v0.58 | IL17A | Ivone Leong Classified gene: IL17A as Amber List (moderate evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| COVID-19 research v0.58 | IL17A | Ivone Leong Added comment: Comment on list classification: Promoted from Red to Amber. There appears to be enough evidence for this gene to be promoted Green; however, will wait for expert review before promoting to Green. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| COVID-19 research v0.58 | IL17A | Ivone Leong Gene: il17a has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| COVID-19 research v0.57 | IL17A | Ivone Leong Phenotypes for gene: IL17A were changed from Arthritis; Immunodeficiency 5 to Arthritis; Immunodeficiency 5; Susceptibility to influenza | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| COVID-19 research v0.56 | IL17A | Ivone Leong Mode of inheritance for gene: IL17A was changed from Unknown to BOTH monoallelic and biallelic, autosomal or pseudoautosomal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| COVID-19 research v0.55 | IL17A | Ivone Leong Publications for gene: IL17A were set to | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| COVID-19 research v0.54 | IL17A | Ivone Leong reviewed gene: IL17A: Rating: ; Mode of pathogenicity: None; Publications: 28860146, 31196204, 27890033, 21703407, 27155288, 29530464; Phenotypes: ; Mode of inheritance: Unknown | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| COVID-19 research v0.36 | IL17A |
Ellen McDonagh gene: IL17A was added gene: IL17A was added to Viral susceptibility. Sources: Expert Review Red,GRID V2.0 Mode of inheritance for gene: IL17A was set to Unknown Phenotypes for gene: IL17A were set to Arthritis; Immunodeficiency 5 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||